These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? Van Brussel I, Lee WP, Rombouts M, Nuyts AH, Heylen M, De Winter BY, Cools N, Schrijvers DM. Autoimmun Rev; 2014 Feb; 13(2):138-50. PubMed ID: 24120737 [Abstract] [Full Text] [Related]
5. Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy. Funes SC, Manrique de Lara A, Altamirano-Lagos MJ, Mackern-Oberti JP, Escobar-Vera J, Kalergis AM. Autoimmun Rev; 2019 Apr; 18(4):359-368. PubMed ID: 30738957 [Abstract] [Full Text] [Related]
15. Redox Regulation of Tolerogenic Dendritic Cells and Regulatory T Cells in the Pathogenesis and Therapy of Autoimmunity. Saksida T, Jevtić B, Djedović N, Miljković Đ, Stojanović I. Antioxid Redox Signal; 2021 Feb 10; 34(5):364-382. PubMed ID: 32458699 [Abstract] [Full Text] [Related]
16. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs. van Kooten C, Stax AS, Woltman AM, Gelderman KA. Handb Exp Pharmacol; 2009 Feb 10; (188):233-49. PubMed ID: 19031029 [Abstract] [Full Text] [Related]